Literature DB >> 29864905

How glycosylation aids tumor angiogenesis: An updated review.

Wei Kang Cheng1, Chern Ein Oon2.   

Abstract

Glycosylation is an enzymatic process in which a carbohydrate is attached to a functional group from another molecule. Glycosylation is a crucial post translational process in protein modification. The tumor microenvironment produces altered glycans that contribute to cancer progression and aggressiveness. Abnormal glycosylation is widely observed in tumor angiogenesis. Despite many attempts to decipher the role of glycosylation in different aspects of cancer, little is known regarding the roles of glycans in angiogenesis. The blood vessels in tumors are often used to transport oxygen and nutrients for tumor progression and metastasis. The crosstalk within the tumor microenvironment can induce angiogenesis by manipulating these glycans to hijack the normal angiogenesis process, thus promoting tumor growth. Abnormal glycosylation has been shown to promote tumor angiogenesis by degrading the extracellular matrix to activate the angiogenic signaling pathways. This review highlights the latest update on how glycosylation can contribute to tumor angiogenesis that may affect treatment outcomes.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Glycans; Glycosylation; Tumor

Mesh:

Year:  2018        PMID: 29864905     DOI: 10.1016/j.biopha.2018.04.119

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  11 in total

1.  Deglycosylated EpCAM regulates proliferation by enhancing autophagy of breast cancer cells via PI3K/Akt/mTOR pathway.

Authors:  Liu Yang; Qijun Wang; Qian Zhao; Fan Yang; Tingjiao Liu; Xiaohua Huang; Qiu Yan; Xuesong Yang
Journal:  Aging (Albany NY)       Date:  2022-01-04       Impact factor: 5.682

2.  Exosome-derived SNHG16 sponging miR-4500 activates HUVEC angiogenesis by targeting GALNT1 via PI3K/Akt/mTOR pathway in hepatocellular carcinoma.

Authors:  Shuangda Li; Yu Qi; Yiran Huang; Yanru Guo; Tong Huang; Li Jia
Journal:  J Physiol Biochem       Date:  2021-08-23       Impact factor: 4.158

3.  SIA-IgG confers poor prognosis and represents a novel therapeutic target in breast cancer.

Authors:  Man Zhang; Jinhua Zheng; Junying Guo; Qiujin Zhang; Juan Du; Xiangfeng Zhao; Zhihua Wang; Qinyuan Liao
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

4.  ST3Gal3 confers paclitaxel‑mediated chemoresistance in ovarian cancer cells by attenuating caspase‑8/3 signaling.

Authors:  Xian Zhang; Xinying Yang; Ming Chen; Shaolie Zheng; Jinyuan Li; Shaoqiang Lin; Xiaoyu Wang
Journal:  Mol Med Rep       Date:  2019-09-26       Impact factor: 2.952

Review 5.  Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer.

Authors:  Nur Izyani Kamaruzman; Noraini Abd Aziz; Chit Laa Poh; Ezharul Hoque Chowdhury
Journal:  Cancers (Basel)       Date:  2019-05-06       Impact factor: 6.639

Review 6.  ST6GAL1: A key player in cancer.

Authors:  Rebecca Garnham; Emma Scott; Karen E Livermore; Jennifer Munkley
Journal:  Oncol Lett       Date:  2019-06-07       Impact factor: 2.967

7.  DPM1 expression as a potential prognostic tumor marker in hepatocellular carcinoma.

Authors:  Ming Li; Shengli Xia; Ping Shi
Journal:  PeerJ       Date:  2020-11-24       Impact factor: 2.984

8.  Site-Specific N-Linked Glycosylation Analysis of Human Carcinoembryonic Antigen by Sheathless Capillary Electrophoresis-Tandem Mass Spectrometry.

Authors:  Laura Pont; Valeriia Kuzyk; Fernando Benavente; Victoria Sanz-Nebot; Oleg A Mayboroda; Manfred Wuhrer; Guinevere S M Lageveen-Kammeijer
Journal:  J Proteome Res       Date:  2021-02-09       Impact factor: 4.466

9.  Carnosine suppresses human colorectal cancer cell proliferation by inducing necroptosis and autophagy and reducing angiogenesis.

Authors:  Shu-Ling Hsieh; Jia-Huei Li; Cheng-Di Dong; Chiu-Wen Chen; Chih-Chung Wu
Journal:  Oncol Lett       Date:  2021-12-09       Impact factor: 2.967

10.  SRSF3 Promotes Angiogenesis in Colorectal Cancer by Splicing SRF.

Authors:  Yinshuang Chen; Man Yang; Fanyi Meng; Yawen Zhang; Mengmeng Wang; Xuqin Guo; Jie Yang; Hongjian Zhang; Haiyang Zhang; Jing Sun; Weipeng Wang
Journal:  Front Oncol       Date:  2022-02-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.